Park Medi World share price nears record ahead of Q1 results

Park Medi World shares extended their recent gains on Monday, with the Park Medi World share price approaching its record high ahead of the company’s Q1 FY27 results announcement later in the day. The stock opened higher at ₹299 on the NSE and quickly climbed to an intraday high of ₹300.60, putting it within ₹4.40 of its all time peak of ₹305. The move came as investors positioned for the quarterly numbers and reacted to the company’s latest expansion into Uttarakhand.

According to NSE data, Park Medi World’s share price rose for a fourth consecutive session during morning trade, reinforcing the short term upward trend in the healthcare stock. The opening print at ₹299 represented a firm start compared with recent closes, and the quick test of ₹300.60 signalled sustained buying interest. While the intraday low was not disclosed, the stock stayed close to the day’s high for much of the early session, indicating limited profit taking. The company’s market capitalisation was not immediately available, but the stock’s proximity to its record level highlighted growing investor focus on its earnings and expansion plans.

Stock Performance

Metric	Value
Close	Not stated
Day Change	Fourth straight session of gains
Intraday High	₹300.60
Intraday Low	Not stated
52-week High	₹305.00
52-week Low	Not stated
Market Cap	Not stated

The stock move was driven by two immediate catalysts, as indicated by the company’s exchange disclosures and trading data. First, Park Medi World has scheduled a board meeting on 3 August 2026 to consider and approve its unaudited Q1 FY27 results, which are expected to give investors clarity on its operating performance in the new financial year. Second, in a filing on Sunday, the healthcare company announced its entry into the Uttarakhand healthcare market, expanding its operational footprint to six states across North India. The combination of an imminent earnings release and a fresh geographic expansion appeared to underpin the four day rally. The company did not provide revenue or profit guidance for the quarter in the available communication, so the buying interest reflects expectations rather than published financial targets.

Park Medi World has not yet released its Q1 FY27 numbers, and no headline figures for revenue, EBITDA or net profit were available at the time of Monday’s morning trade. The board meeting set for 3 August 2026 is expected to approve the unaudited financial results for the quarter ended June 2026. Investors will be watching for trends in patient volumes, operating margins and any impact from the company’s multi state presence. In the absence of published financial data, the share price reaction ahead of the announcement suggests the market is anticipating continuity or improvement in performance compared with prior periods, though that will only be confirmed once the results are filed with the exchanges.

The company’s latest strategic move, its foray into Uttarakhand, adds another state to Park Medi World’s network in North India and takes its presence to six states in the region. The exchange filing did not specify the size of the planned facilities, investment outlay or commissioning timeline, but the expansion signals a continued focus on building scale in tier two and tier three markets. For a healthcare operator, a wider geographic footprint can support higher patient inflows and better utilisation of clinical resources, although it also increases operating costs and execution risk. The market’s positive reaction indicates that investors currently see the Uttarakhand entry as a growth opportunity rather than a drag.

Key Event

Item	Details
Event	Board meeting to approve unaudited Q1 FY27 results
Value	Financial figures not yet disclosed
Timeline	3 August 2026
Counterparty	Not applicable

Park Medi World did not issue detailed management commentary with the brief exchange notice about the board meeting and expansion, and no earnings call remarks were available yet. The company’s communication focused on the scheduling of the Q1 FY27 results approval and the confirmation of its entry into Uttarakhand. Without direct quotes from executives, the market is relying on the strategic direction implied by the expansion and the timing of the results rather than explicit management guidance.

Park Medi World operates in the healthcare sector, with a growing presence across North Indian states. The addition of Uttarakhand takes its operational reach to six states, which positions the company to tap into regional demand for hospital and medical services. In recent sessions, the stock has been in a sustained uptrend, culminating in Monday’s test of ₹300.60 as investors awaited the Q1 FY27 print. The existing record high of ₹305 now serves as a near term technical reference point for traders watching the Park Medi World share price today.

The next key catalyst for the stock will be the release of the unaudited Q1 FY27 results following the board meeting on 3 August 2026. Investors will scrutinise the numbers for any indication of how the expanded geographic footprint is affecting growth and profitability. Further details on the Uttarakhand expansion, including project timelines and capacity, could also influence sentiment once disclosed in more comprehensive filings or presentations.